KRAS and cancer: Monoclonal antibodies (mAbs), immune checkpoint inhibitors (ICI), cytokine therapy, cancer vaccines, and CAR-T cell therapy are the commonly available immunotherapies that could be harnessed to combat KRAS mutated cancers [15, 17, 18].